The role of the Hsp90/Akt pathway in myocardial calpain-induced caspase-3 activation and apoptosis during sepsis

BMC Cardiovasc Disord. 2013 Feb 20:13:8. doi: 10.1186/1471-2261-13-8.

Abstract

Background: Recent studies have demonstrated that myocardial calpain triggers caspase-3 activation and myocardial apoptosis in models of sepsis, whereas the inhibition of calpain activity down-regulates myocardial caspase-3 activation and apoptosis. However, the mechanism underlying this pathological process is unclear. Therefore, in this study, our aim was to explore whether the Hsp90/Akt signaling pathway plays a role in the induction of myocardial calpain activity, caspase-3 activation and apoptosis in the septic mice.

Methods: Adult male C57 mice were injected with lipopolysaccharide (LPS, 4 mg/kg, i.p.) to induce sepsis. Next, myocardial caspase-3 activity and the levels of Hsp90/p-Akt (phospho-Akt) proteins were detected, and apoptotic cells were assessed by performing the TUNEL assay.

Results: In the septic mice, there was an increase in myocardial calpain and caspase-3 activity in addition to an increase in the number of apoptotic cells; however, there was a time-dependent decrease in myocardial Hsp90/p-Akt protein levels. The administration of calpain inhibitors (calpain inhibitor-Ш or PD150606) prevented the LPS-induced degradation of myocardial Hsp90/p-Akt protein and its expression in cardiomyocytes in addition to inhibiting myocardial caspase-3 activation and apoptosis. The inhibition of Hsp90 by pretreatment with 17-AAG induced p-Akt degradation, and the inhibition of Akt activity by pretreatment with wortmannin resulted in caspase-3 activation in wildtype C57 murine heart tissues.

Conclusions: Myocardial calpain induces myocardial caspase-3 activation and apoptosis in septic mice via the activation of the Hsp90/Akt pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylates / pharmacology
  • Androstadienes / pharmacology
  • Animals
  • Apoptosis*
  • Benzoquinones / pharmacology
  • Calpain / antagonists & inhibitors
  • Calpain / metabolism*
  • Caspase 3 / metabolism*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dipeptides / pharmacology
  • Disease Models, Animal
  • Enzyme Activation
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors
  • HSP90 Heat-Shock Proteins / metabolism*
  • In Situ Nick-End Labeling
  • Lactams, Macrocyclic / pharmacology
  • Lipopolysaccharides
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocardium / enzymology*
  • Myocardium / pathology
  • Phosphatidylinositol 3-Kinase / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Sepsis / chemically induced
  • Sepsis / enzymology*
  • Sepsis / pathology
  • Signal Transduction* / drug effects
  • Time Factors
  • Wortmannin

Substances

  • Acrylates
  • Androstadienes
  • Benzoquinones
  • Cysteine Proteinase Inhibitors
  • Dipeptides
  • HSP90 Heat-Shock Proteins
  • Lactams, Macrocyclic
  • Lipopolysaccharides
  • PD 150606
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • tanespimycin
  • Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
  • Calpain
  • Casp3 protein, mouse
  • Caspase 3
  • calpain inhibitor III
  • Wortmannin